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Abstract
Background: Mycobacterium tuberculosis (MTB) has been classified into 4 main lineages. Some reports have associated
certain lineages with particular clinical phenotypes, but there is still insufficient information regarding the clinical and
epidemiologic implications of MTB lineage variation.
Methods: Using large sequence polymorphisms we classified MTB isolates from a population-based study in Montreal,
Canada into the 4 major lineages, and identified the associated clinical and epidemiologic features. In addition, IS6110-RFLP
and spoligotyping were used as indicators of recent TB transmission. The study population was divided into a derivation
cohort, diagnosed between 2001 and 2007, and a separate validation cohort, diagnosed between 1996 and 2000.
Results: In the derivation cohort, when compared to the other MTB lineages, the East African-Indian (EAI) lineage was
associated with lower rates of TB transmission, as measured by: positive TST among close contacts of pulmonary TB cases
(adjusted odds ratio 0.6: [95% confidence interval 0.4–0.9]), and clustered TB cases (0.3: [,0.001–0.6]). Severe forms of TB
were also less likely among the EAI group (0.4: [,0.001–0.8]). There were no significant differences when comparing
patients with the other MTB lineages. In the validation cohort, the EAI lineage was associated with lower rates of positive
TST among contacts (0.5: [0.3–0.9]) and a trend towards less clustered TB cases (0.5: [0.1–1.8]) when compared to the other
lineages. Disease severity among the different groups was not significantly different in the validation cohort.
Conclusions: We conclude that in Montreal, EAI strains were associated with reduced transmission compared to other MTB
lineages.
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Introduction
Tuberculosis (TB) is a contagious disease caused by Mycobacte-
rium tuberculosis (MTB). Despite the availability of adequate
diagnostic tests and effective treatment, TB accounts for 9.2
million new illnesses and nearly 2 million deaths annually [1]. This
is explained in part by environmental risk factors, such as poorly
ventilated and crowded conditions, poverty, and lack of access to
medical care. Host-related factors, such as malnutrition or HIV
co-infection, play a major role, but the contribution of bacterial
factors is relatively unknown. Recently a robust method has been
developed to define major MTB lineages, which is based on the
detection of large sequence polymorphisms (LSPs) or single
nucleotide polymorphisms (SNPs) [2–4]. Studies using these
techniques have identified six major lineages, 4 sub-divide MTB
and 2 sub-divide M. africanum [3,5]. These lineages have distinct
geographic distributions and have been tentatively linked with
differing epidemiologic and clinical profiles.
Experimental laboratory studies have provided evidence
suggesting that distinct MTB strains may have variable virulence
properties. For example, there are several reports describing
apparently enhanced in vivo virulence of certain members of the
‘‘Beijing’’ lineage [6–8]. In at least some instances, this enhanced
virulence appears to be related to the production of a complex
phenolic glycolipid (PGL-tb) which inhibits macrophage proin-
flammatory cytokine release [9,10]. However there is little
published evidence that these laboratory findings are associated
with important clinical consequences. Hence environmental and
host related risk factors are still considered the most important
factors influencing disease transmission and severity.
Combined data from 49 studies concluded that the Beijing
lineage has emerged in many areas of the world including Cuba,
the former Soviet Union, Vietnam, South Africa, Malawi, and
Argentina [11]. For example, Beijing strains did not exist in Cape
Town (South Africa) prior to 1965, but now account for 20% of all
TB cases there. Interestingly, in these Cape Town studies, patients
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AFB smear positive in their sputum [12–14]. These findings have
led to the suggestion that strains belonging to the Beijing lineage
possess unique attributes that confer an increased ability to cause
disease and to transmit within certain geographic settings or ethnic
groups [15]. In contrast, in a prospective study of the development
of active TB among close contacts of patients with active TB, the
proportion with disease caused by M. africanum was significantly
lower than with other MTB strains [16]. Very little information is
presently available regarding clinical features attributable to the
other main TB lineages, including the East African-Indian (EAI)
lineage that is the focus of the current study.
The objective of the present study was to investigate the
association of the major MTB lineages with: transmissibility of
infection and disease, disease severity, and drug resistance to first
line anti-TB drugs.
Methods
Study population
The study cohort consisted of all persons resident in Montreal
diagnosed with active TB between January 1996 and May 2007.
Clinical and demographic data for the TB cases, and their close
contacts was obtained from the records of the Public Health Unit,
and hospital medical records.
This cohort of TB cases was divided into a derivation cohort,
diagnosed between January 2001 and May 2007, and a validation
cohort, diagnosed between January 1996 and December 2000.
Because the analyses in the derivation cohort identified the EAI
lineage as potentially of greatest interest, we restricted the
validation cohort to persons born in countries (Afghanistan,
Bangladesh, Djibouti, Ethiopia, India, Kenya, Pakistan, Somalia,
Sri Lanka, and Tanzania) where EAI strains are commonly
encountered [3,5].
We included TB patients, whose TB diagnosis was based on
culture isolation of MTB, and household or family contacts of
pulmonary TB patients. HIV co-infected patients and their
contacts and patients infected with M. Africanum and their contacts
were excluded.
Ethics statement
The study was approved by the Biomedical - C Research ethics
board of the McGill University Health Centre. Patients’ consent
was not required because there was no direct contact with the
patients and the data was gathered anonymously. The above
named research ethics board waived the need for consent.
Laboratory methods
Mycobacterial isolates of all cohort members were retrieved
from the Quebec provincial reference lab [3]. The main MTB
lineages were identified using PCR-based detection of Large
Sequence Polymorphisms (LSPs) as previously described [3]. The
identified LSP deletions were as follows: RD105 for the East Asian
or Beijing lineage, RD239 for the Indo-Oceanic lineage, RD750
for the EAI lineage, and the Euro-American lineage strains were
identified using sequence analysis of a portion of the polyketide
synthase 1–15 gene (pks1-15).
Disease transmission was assessed using IS6110 RFLP (restric-
tion fragment length polymorphism) [17]. Spoligotyping was
performed on strains with less than 6 RFLP ‘‘bands’’ [3].
Indicators of transmission and disease severity
We estimated the likelihood of a previous positive TST in each
contact using the formula: PTBI=[12(1-ARI)
age] [18], where
PTBI=the probability of TB infection, ARI=the average estimated annual
risk of TB infection in each contact’s country of origin, and Age=their age
when they left that country. ARI was estimated from the WHO
estimated incidence of smear positive TB in their country of origin
using the Styblo formula [1,19]. The probability of previous TB
infection in each contact was summed to give an estimated
proportion of previous TB infection for each lineage group, and
then subtracted from the observed proportion with positive TST
to estimate the proportion with recent TB infection (i.e. equivalent
to TST conversion). The second transmission indicator was the
proportion of active cases for each lineage group in clusters with
identical RFLP or spoligotype patterns.
Severe disease was defined as: disseminated TB, TB meningitis,
bilateral lung consolidation with 4 or 5 lobes involved, or death
before or during anti-tuberculous therapy.
Statistical analysis
Associations between clinical characteristics and MTB strain
lineage were tested for significance using the chi-square or Fisher’s
exact tests for categorical, and t tests or analysis of variance for
continuous variables. Differences in outcomes between groups
were expressed as odds ratios and 95% confidence intervals.
Multiple logistic regression analysis was performed to adjust for
potential confounding covariates. All analyses were conducted
using SAS (version 9.2) software.
Results
Derivation cohort
A total of 816 patients were diagnosed with culture positive
active TB on the island of Montreal between January 2001 and
May 2007. Of these patients 17% were born in Canada, 19.3%
were foreign-born from the Americas or the Caribbean, 8.6%
originated from Europe, 21.8% from Africa and the Middle East,
12.5% from the Indian subcontinent, and 20.7% from Asia. From
the total number, 78 patients were excluded because of
unsuccessful DNA extraction or insufficient clinical data. In
addition, 62 HIV sero-positive patients were excluded because of
the profound effect HIV co-infection can have on clinical
outcomes [20,21]. We also excluded patients infected with M.
africanum due to the small numbers of patients involved (3 patients).
This left 678 patients with active TB who were analyzed, of whom
466 had pulmonary disease – these patients had 1339 close
contacts; for more details about population selection see Figure S1.
The most commonly isolated MTB lineage in this cohort
belonged to the Euro-American lineage (66.7%), 9.6% were
Beijing, 17.7% were Indo-Oceanic and 6% were EAI strains.
Except for the TB incidence in the patients’ countries of origin and
the age of contacts, the environmental and host-related risk factors
were comparable between the groups infected with EAI and non-
EAI MTB lineages (Table 1).
In this derivation cohort, as seen in Figure 1, the EAI lineage
was less likely to be associated with RFLP clustered cases (0% vs.
19%, p,0.001) when compared to the other lineages. When we
stratified our subjects based on the disease site (pulmonary and
extra-pulmonary), the result among subjects with pulmonary TB
only was the same (0 vs. 19%; p: 0.02). Close contacts of
pulmonary TB patients with disease due to the EAI lineage were
less likely to have positive TST (overall) (39% vs. 51%, p: 0.046).
Using the methods described above to identify recent TB
infections, the estimated proportions with recent TB infection
(equivalent to TST conversion) among contacts of EAI and non-
EAI infected patients were 17% and 29%, respectively (Figure 2).
The EAI lineage was also less likely to be associated with instances
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PLoS ONE | www.plosone.org 2 September 2011 | Volume 6 | Issue 9 | e25075of severe TB (0% vs. 10%, p: 0.025), whilst the proportion with
drug resistant TB was identical (10% vs. 10%, p: 1.0), (Figure 1).
Although not statistically significant, the Beijing lineage was
associated with a somewhat higher proportion of positive TST
among contacts (55% vs. 50%, p: 0.37) and drug resistance to one
or more anti-TB drugs (14% vs. 10%, p: 0.22) as compared to the
other lineages combined. These strains were also associated with a
lower proportion in RFLP clusters (9% vs. 19%, p: 0.05) and
severe disease (8% vs. 10%, p: 0.6). There were also no significant
differences in primary outcomes, when comparing patients across
the other MTB lineages.
Considering the other clinical features (secondary outcomes),
the EAI lineage was associated with a higher proportion of TB
lymphadenitis (34% vs. 22%, p: 0.067) and extra-pulmonary TB
(45% vs. 30%, p: 0.05), and lower proportion of weight loss (23%
vs. 38%, p: 0.066) as compared to the other lineages; for more
details about clinical features associated with each of the four
MTB lineages see Table S2.
Validation Cohort
In total, 91 patients with active TB, extractable DNA, and
adequate clinical information were identified, along with 229 close
contacts of the pulmonary TB patients within this group; refer to
Figure S2 for more details. Of those with active TB, 36 (40%) were
infected with EAI lineage strains. The environmental and host-
related risk factors were comparable between the EAI and non-
EAI groups, except for the TB prevalence in the patients’ countries
of origin (Table 1). For this validation cohort, the EAI lineage was
Table 1. Patient characteristics associated with East African-Indian and other Mycobacterium tuberculosis lineages.
Derivation Cohort Validation cohort
EAI Non-EAI P-value EAI Non-EAI P-value
A) TB patients (i.e. index cases).
Total number 41 637 36 55
Age, mean (SD) 47 (21) 44 (20) 0.38 40 (20) 36 (15) 0.3
Male sex, N (%) 20 (49) 337 (54) 0.53 25 (69) 37 (68.5) 0.9
Immigrants from high TB prevalence country*, N (%) 36 (88) 376 (61) -
{ 36 (100) 42 (76) -
{
Years in Canada
{, mean (SD) 8 (10) 10 (12) 0.24 5.3 (8.2) 4.7 (5.8) 0.7
Co-morbidities
1, N (%) 13 (32) 215 (35) 0.8 9 (26) 16 (31) 0.6
History of smoking, N (%) 5 (19) 155 (31) 0.18 6 (23) 14(33) 0.4
Alcohol abuse, N (%) 4(15) 89 (18) 0.69 3(12) 5 (13) 1.0
IV drug use, N 0 4 (0.8) 0.63 0 0 -
Past TB infection, N (%) 2 (5) 69 (11) 0.23 2 (6) 5 (11) 0.7
B) Close contacts of pulmonary TB patients.
Total number 74 1265 86 143
Age, mean (SD) 35 (23) 29 (20) 0.05 26 (19) 21 (16) 0.1
Male sex
ll, N (%) 13 (45) 170 (51) 0.55 - - -
Immigrants from high TB prevalence country*, N (%) 46 (62) 675 (53) -
{ 84 (98) 121 (85) -
{
Years in Canada
{, mean (SD) 10 (10) 9 (10) 0.7 5.3 (8) 3.6 (3.8) 0.08
Abbreviations: EAI=East African-Indian; TB=tuberculosis; N=number; SD=standard deviation IV=intravenous.
*Estimated TB prevalence .150 per 100, 000, based on the 2009 World Health Organization reports (1);
{country of origin was basis for assessment into groups, hence statistical testing would not be appropriate;
{number of years of stay in Canada since immigration – for foreign born only;
1co-morbidities include chronic pulmonary diseases, diabetes, cardiac diseases, renal diseases, liver diseases, and non-HIV immunosuppressive disorders (e.g.
malignancies, immunosuppressive medications);
ll73% missing values in the derivation cohort and completely missing in the validation cohort.
For comparison between the 3 major non-EAI lineages see Table S1.
doi:10.1371/journal.pone.0025075.t001
Figure 1. Proportion of recent tuberculosis transmission,
severe disease, and drug resistant tuberculosis among deriva-
tion cohort patients. A comparison between patients within each
MTB lineage group. Recent TB transmission is indicated by RFLP
clusters. Abbreviations: RFLP=restriction fragment length polymor-
phism; DR-TB=drug resistant tuberculosis. *Severe TB indicates
disseminated TB, TB meningitis, extensive bilateral lung consolidation
or death during the course of TB therapy.
doi:10.1371/journal.pone.0025075.g001
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TST among contacts (44% vs. 58%, p: 0.04), and a lower
proportion with estimated recent infection (17% versus 33%, p:
0.01). The EAI lineage was also associated with somewhat fewer
RFLP clustered cases (3% vs. 13%, p: 0.14) when compared to the
other lineages. Because of the small number of patients with severe
TB, 4 among the EAI group (2 of whom died during TB therapy
due to myocardial infarction and brain malignancy) and 3 among
the non-EAI group, we could not assess any associations between
strain lineage and clinical severity in this second cohort.
Multivariate analysis
After adjustment for age and probability of previous latent TB,
the EAI lineage was associated with significantly lower odds of
having a positive TST among contacts in the derivation cohort
(adjusted OR 0.6: [95% confidence interval 0.4–0.9]) and the
validation cohort (0.5: [0.3–0.9]). The odds of being part of an
RFLP cluster or having severe TB, were also significantly lower
among the EAI group in the derivation cohort (adjusted
ORs=0.3: [,0.001–0.6] and 0.3: [,0.001–0.8] respectively),
but were not significantly different in the validation cohort
(adjusted ORs=0.5: [0.1–1.8] and 1.4: [0.4–11] respectively); see
Tables 2 and 3 for details.
Discussion
In our Montreal-based study, 4 major MTB lineages were
identified and the associated clinical features were compared. In
contrast to studies carried out in other populations where Beijing
isolates were associated with greater virulence, and transmissibility
[11,22,23] or with drug–resistance [11,24], these features were not
associated with this lineage in Montreal. On the other hand, in our
study the EAI lineage was less likely to cause infection or disease
transmission, or to be associated with severe clinical manifestations
when compared to the other 3 MTB lineages. Considering the
geographic distribution of the EAI lineage, our finding is
concordant with laboratory evidence from the 1960’s suggesting
that MTB isolates from Southern Indian patients were less virulent
compared to isolates from British patients [25]. Although very
difficult to confirm, it is possible that at least some of these
Southern Indian isolates belonged to the EAI lineage.
In contrast to our findings, a strain belonging to the EAI lineage
(the ‘‘CH strain’’) has recently been identified as being responsible for
a large tuberculosis outbreak in the United Kingdom [26]. Despite
the identification of some anti-inflammatory characteristics of the
CH-MTB strain that can influence the innate immune response, and
which makes it plausible for this strain to be highly transmissible, no
population based epidemiological study has compared the transmis-
sibility of this strain to other MTB strains [27]. It is also interesting to
note that the genomic deletionthat was identified asbeing responsible
for the anti-inflammatory properties of the CH bacteria (the RD750
deletion) is also absent from each of our EAI strains.
Our study limitations include the relatively small number of
patients infected with the EAI lineage, which is the group of
interest in this study. In addition, there are potential confounding
effects related to patient’s ethnicity and socioeconomic status,
which were difficult to control in our analysis. Studying TB related
outcomes in a country like Canada, where the TB control program
has substantial resources, can substantially limit TB transmission
and reduce unfavourable disease outcomes, limiting our power to
detect important relationships. M. africanum, which has been
associated with a lower rate of disease transmission compared to
Figure 2. Estimated proportion of recent versus remote
tuberculosis infection among derivation cohort contacts. A
comparison between close contacts of active pulmonary TB patients
within each MTB lineage group. Light coloured bars: proportion
estimated to have remote TB infection based on the calculated
probability of latent TB at the time of immigration to Canada (see
methods for details). Dark coloured bars: remaining TST positive (out of
total) assumed to have recent TB infection (i.e. equivalent to TST
conversion). Abbreviations: TB=tuberculosis.
doi:10.1371/journal.pone.0025075.g002
Table 2. Primary outcomes associated with East African-
Indian lineage and other lineages combined in the derivation
cohort.
East African-Indian
(EAI) Non-EAI* P-value
+TST
N/Tot. (%) 29/74 (39) 647/1265 (51) 0.046
Crude OR (CI) 0.6 (0.4–0.99) 1.0 (Ref.)
Adjusted OR (CI)
{ 0.6 (0.4–0.93) 1.0 (Ref.)
RFLP Cluster
N/Tot. (%) 0/41 (0) 124/637 (19) ,0.001
Crude OR (CI)
{ 0.3 (,0.001–0.6) 1.0 (Ref.)
Adjusted OR (CI)
1 0.3 (,0.001–0.6) 1.0 (Ref.)
Severe TB
ll
N/Tot. (%) 0/41 (0) 64/637 (10) 0.025
Crude OR (CI)
{ 0. 4 (,0.001–0.94) 1.0 (Ref.)
Adjusted OR (CI)
1 0.3 (,0.001–0.8) 1.0 (Ref.)
Drug resistance
N/Tot. (%) 4/41 (10) 62/622 (10) 0.965
Crude OR (CI) 1.0 (0.4–3.0) 1.0 (Ref.)
Adjusted OR (CI)** 1.2 (0.4–3.4) 1.0 (Ref.)
Abbreviations: N=number; Tot=total; +TST=positive tuberculin skin test;
CI=95% confidence interval; Ref.=reference; TB=tuberculosis.
*Indicates Beijing, Indo-Oceanic and Euro-American lineages combined;
{adjusted for age and probability of latent TB at the time of immigration,
contact’s sex and comorbidity information are not available;
{estimated using exact logistic regression analysis;
1adjusted for age, adjustment for multiple covariates was technically difficult in
the presence of zero events;
llsevere TB indicates disseminated TB, TB meningitis, extensive bilateral lung
consolidation and/or death during the course of TB therapy;
**adjusted for age, sex, co-morbidities, smoking history, alcohol abuse, IV drug
use, history of previous TB, and TB prevalence in the countries of origin.
doi:10.1371/journal.pone.0025075.t002
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the very small numbers of patients infected with these strains.
Considering that disease transmission is less likely from patients
with extra-pulmonary TB, transmissibility of EAI lineage as
compared to other MTB lineages might have been less because
more patients with EAI disease had extra-pulmonary TB in our
derivation cohort. However, when our analysis was restricted to
contacts of patients with pulmonary TB, or to RFLP clustering
among pulmonary TB cases, TB transmissibility was reduced
among EAI-MTB infected group.
A major strength of our study was that we employed a second
validation cohort to test for potentially spurious associations in the
first, derivation cohort. By focusing on a specific sub-population
with a common geographic background, where the EAI lineage is
most frequently isolated, we were able to show that the lower risk of
TB transmission among EAI-infected patients and their contacts
was reproducible across different time-windows in Montreal, and
within a more restricted comparison group – in an attempt to limit
the ethnic(and presumed genetic) diversity of the TB cases and their
contacts. Although the proportions of RFLP clustered cases appear
different in the two cohorts (among EAI groups were 0% [95%CI:
0–9%] versus 3% [0.1–15%] and among the non-EAI groups were
19% [17–23%] versus 13% [6–23%]), we think that this is mainly
related to random variations between the two samples, since the
estimates from the two samples are similar and their 95% CIs are
overlapping. Another strength is related to the global distribution of
our study sample; 83% of patients were foreign-born from 80
different countries in 16 different geographic regions [3]. Because of
the phylogeographic diversity of the major MTB lineages, such a
global study sample is crucial to perform comparative analyses to
identify associations between individual strain lineages (or sub-
lineages thereof) and clinical disease features [3,5].
Our study observations, which characterize major MTB
lineages based on a comprehensive clinical assessment of a diverse
population, provides some interesting insights into the potential
pathogenicity of the EAI-MTB lineage and suggests some
potential clinical implications, although independent validation
of these findings in another setting is needed. Therefore we suggest
studies using deletion analysis to classify strains in the Indian sub-
continent area to see whether the observed associations in this
study are also seen in the country of origin of these bacteria. As
part of future risk assessments, MTB lineage detection could
influence the management plan among TB patients, or the extent
of TB screening among contacts of a TB patient.
Conclusions
This study provides evidence that the East African-Indian lineage
strains are associated with a lower risk of transmission and, possibly,
a lower risk of developing severe forms of active disease. In addition,
forourMontreal cohort,Beijing lineagestrainswerefoundnottobe
associated with enhanced transmissibility or disease severity.
Supporting Information
Figure S1 Population selection in the derivation cohort.
(A) Cases. (B) Contacts. Abbreviations: PTB=pulmonary tuber-
culosis.
(TIF)
Figure S2 Population selection in the validation cohort.
(A) Cases. (B) Contacts. Abbreviations: PTB=pulmonary tuber-
culosis.
(TIF)
Table S1 Patient characteristics associated with East
African-Indian and other Mycobacterium tuberculosis
lineages in the derivation cohort. Abbreviations: N=num-
ber; TB=tuberculosis; IV=intravenous. * P-value for difference
between all 4 groups, using chi square or analysis of variance (see
methods; degrees of freedom=3);
{estimated TB prevalence .150
per 100, 000, based on the 2009 World Health Organization
reports (1);
{ measuring p-value is not appropriate because of pre-
assigned differences;
1 number of years of stay in Canada since
immigration – for foreign born only;
ll co-morbidities include
chronic pulmonary diseases, diabetes, cardiac diseases, renal
diseases, liver diseases, and non-HIV immunosuppressive disor-
ders (e.g. malignancies, immunosuppressive medications); ** 73%
missing values.
(DOC)
Table S2 Clinical features associated with major My-
cobacterium tuberculosis lineages in derivation cohort.
Abbreviations: N=number; TB=tuberculosis. *Includes all non-
East African-Indian lineages combined;
{ p-value for difference
between East African-Indian lineage and other lineages combined,
using chi square (see methods; degrees of freedom=1);
{the
disease site is missing for 3 patients;
1includes patients who have
both pulmonary and extra-pulmonary combined.
(DOC)
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